Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
Journal of clinical oncology / Englische Ausgabe - 34(2016), 28, Seite 3400-3408 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Colleoni, M [VerfasserIn] |
---|
Links: |
---|
RVK: |
---|
doi: |
10.1200/JCO.2015.65.6595 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1978226098 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1978226098 | ||
003 | DE-627 | ||
005 | 20230714200940.0 | ||
007 | tu | ||
008 | 160719s2016 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1200/JCO.2015.65.6595 |2 doi | |
028 | 5 | 2 | |a PQ20161201 |
035 | |a (DE-627)OLC1978226098 | ||
035 | |a (DE-599)GBVOLC1978226098 | ||
035 | |a (PRQ)crossref_primary_10_1200_JCO_2015_65_65950 | ||
035 | |a (KEY)0186196420160000034002803400lowdoseoralcyclophosphamideandmethotrexatemaintena | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 070 |a 610 |q DE-600 |
084 | |a XA 52760 |q AVZ |2 rvk | ||
100 | 1 | |a Colleoni, M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00 |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Gray, K. P |4 oth | |
700 | 1 | |a Gelber, S |4 oth | |
700 | 1 | |a Lang, I |4 oth | |
700 | 1 | |a Thurlimann, B |4 oth | |
700 | 1 | |a Gianni, L |4 oth | |
700 | 1 | |a Abdi, E. A |4 oth | |
700 | 1 | |a Gomez, H. L |4 oth | |
700 | 1 | |a Linderholm, B. K |4 oth | |
700 | 1 | |a Puglisi, F |4 oth | |
700 | 1 | |a Tondini, C |4 oth | |
700 | 1 | |a Kralidis, E |4 oth | |
700 | 1 | |a Eniu, A |4 oth | |
700 | 1 | |a Cagossi, K |4 oth | |
700 | 1 | |a Rauch, D |4 oth | |
700 | 1 | |a Chirgwin, J |4 oth | |
700 | 1 | |a Gelber, R. D |4 oth | |
700 | 1 | |a Regan, M. M |4 oth | |
700 | 1 | |a Coates, A. S |4 oth | |
700 | 1 | |a Price, K. N |4 oth | |
700 | 1 | |a Viale, G |4 oth | |
700 | 1 | |a Goldhirsch, A |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology / Englische Ausgabe |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 34(2016), 28, Seite 3400-3408 |w (DE-627)130399477 |w (DE-600)604914-X |w (DE-576)015903079 |x 0732-183X |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2016 |g number:28 |g pages:3400-3408 |
856 | 4 | 1 | |u http://dx.doi.org/10.1200/JCO.2015.65.6595 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2082 | ||
912 | |a GBV_ILN_2424 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
936 | r | v | |a XA 52760 |
951 | |a AR | ||
952 | |d 34 |j 2016 |e 28 |h 3400-3408 |